MR imaging evaluation for residual diseases after the lumpectomy of malignant breast tumors

WANG Li-Jun,WANG Deng-bin,LI Zhi
DOI: https://doi.org/10.3969/j.issn.1000-0313.2013.06.017
2013-01-01
Abstract:Objective:To investigate the application of MRI in evaluating the residual disease in the prior lumpectomy site.Methods:A retrospective analysis of 87 cases of breast tumor resection from september 2009 to Septmber 2012 was undertaken.In these 87 patients the pathological report was malignant and reoperation was required.The patients underwent MR examination before operation and BI-RADS classification of the MRI findings was used.Results:In 28 of 87 cases there were residual diseases confirmed by pathology.In 42 cases of BI-RADS 2 or 4 there were residual diseases in four cases,and 21 of 42 cases(50%) underwent breast conservative surgery.In 45 cases of BI-RADS 4 or 5,there were residual diseases in 24 cases,and 4 from 45 cases(8.9%) underwent breast conservative surgery.The sensitively,specificity,positive predictive value and negative predictive value of MR imaging for diagnosing residual diseases were 85.7%,64.4%,53.3% and 90.4% respectively.From the various MR imaging findings,the positive predictive value of duct-like enhancement,segmental enhancement and nodular enhancement for suggesting presence of residual diseases were 77.8%,71.4% and 54.5% respectively.Conclusion:BI-RADS classification of breast MR imaging are helpful for assessment of residual diseases after breast lumpectomy for malignant tumors,duct-like enhancement,segmental enhancement and modular enhancement are suggestive for residual diseases.
What problem does this paper attempt to address?